177 related articles for article (PubMed ID: 33588110)
1. Effect of Follow-Up Surveillance After Curative-Intent Treatment of NSCLC on Detection of New and Recurrent Disease, Retreatment, and Survival: A Systematic Review and Meta-Analysis.
Stirling RG; Chau C; Shareh A; Zalcberg J; Fischer BM
J Thorac Oncol; 2021 May; 16(5):784-797. PubMed ID: 33588110
[TBL] [Abstract][Full Text] [Related]
2. Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Colt HG; Murgu SD; Korst RJ; Slatore CG; Unger M; Quadrelli S
Chest; 2013 May; 143(5 Suppl):e437S-e454S. PubMed ID: 23649451
[TBL] [Abstract][Full Text] [Related]
3. Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition).
Rubins J; Unger M; Colice GL;
Chest; 2007 Sep; 132(3 Suppl):355S-367S. PubMed ID: 17873180
[TBL] [Abstract][Full Text] [Related]
4. Follow-up and surveillance of the lung cancer patient following curative-intent therapy.
Colice GL; Rubins J; Unger M;
Chest; 2003 Jan; 123(1 Suppl):272S-283S. PubMed ID: 12527585
[TBL] [Abstract][Full Text] [Related]
5. Detection of second primary lung cancers on surveillance imaging following stereotactic ablative radiotherapy for non-small cell lung cancer.
Aldin MK; Qi L; Zhou X; Kahn LA; Daly ME
Clin Lung Cancer; 2022 May; 23(3):e222-e230. PubMed ID: 34922827
[TBL] [Abstract][Full Text] [Related]
6. Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline.
Schneider BJ; Ismaila N; Aerts J; Chiles C; Daly ME; Detterbeck FC; Hearn JWD; Katz SI; Leighl NB; Levy B; Meyers B; Murgu S; Nekhlyudov L; Santos ES; Singh N; Tashbar J; Yankelevitz D; Altorki N
J Clin Oncol; 2020 Mar; 38(7):753-766. PubMed ID: 31829901
[TBL] [Abstract][Full Text] [Related]
7. Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation.
Liu W; Zheng Y; Zou R; Shen J; He W; Yang Z; Zhang Y; Li B; Yuan Y
BMC Cancer; 2018 Nov; 18(1):1186. PubMed ID: 30497418
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Performance of ¹⁸F-FDG PET and PET/CT for the Detection of Recurrent Esophageal Cancer After Treatment with Curative Intent: A Systematic Review and Meta-Analysis.
Goense L; van Rossum PS; Reitsma JB; Lam MG; Meijer GJ; van Vulpen M; Ruurda JP; van Hillegersberg R
J Nucl Med; 2015 Jul; 56(7):995-1002. PubMed ID: 25952733
[TBL] [Abstract][Full Text] [Related]
9. Let us not underestimate the long-term risk of SPLC after surgical resection of NSCLC.
Leroy T; Monnet E; Guerzider S; Jacoulet P; De Bari B; Falcoz PE; Gainet-Brun M; Lahourcade J; Alfreijat F; Almotlak H; Adotevi O; Pernet D; Polio JC; Desmarets M; Woronoff AS; Westeel V
Lung Cancer; 2019 Nov; 137():23-30. PubMed ID: 31521979
[TBL] [Abstract][Full Text] [Related]
10. Adherence to surveillance guidelines in resected NSCLC: Physician compliance and impact on outcomes.
Ho C; Siegfried J; Remo K; Laskin J
Lung Cancer; 2017 Oct; 112():176-180. PubMed ID: 29191592
[TBL] [Abstract][Full Text] [Related]
11. Survival benefits from follow-up of patients with lung cancer: a systematic review and meta-analysis.
Calman L; Beaver K; Hind D; Lorigan P; Roberts C; Lloyd-Jones M
J Thorac Oncol; 2011 Dec; 6(12):1993-2004. PubMed ID: 21892108
[TBL] [Abstract][Full Text] [Related]
12. Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer.
Reddy JP; Tang C; Shih T; Kim B; Kim C; Nguyen QN; Welsh J; Benveniste M; Zhang J; Liao Z; Gomez DR
Clin Lung Cancer; 2017 Mar; 18(2):141-148. PubMed ID: 27913215
[TBL] [Abstract][Full Text] [Related]
13. The risk of second primary tumors after resection of stage I nonsmall cell lung cancer.
Rice D; Kim HW; Sabichi A; Lippman S; Lee JJ; Williams B; Vaporciyan A; Smythe WR; Swisher S; Walsh G; Putnam JB; Hong WK; Roth J
Ann Thorac Surg; 2003 Oct; 76(4):1001-7; discussion 1007-8. PubMed ID: 14529975
[TBL] [Abstract][Full Text] [Related]
14. Brief report: risk stratification following curative therapy for stage I NSCLC.
Butts E; Gococo-Benore D; Pai T; Moustafa MA; Heng F; Chen R; Zhao Y; Manochakian R; Lou Y
Front Oncol; 2023; 13():1250315. PubMed ID: 37645428
[TBL] [Abstract][Full Text] [Related]
15. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.
Frank A; Lefkowitz D; Jaeger S; Gobar L; Sunderland J; Gupta N; Scott W; Mailliard J; Lynch H; Bishop J
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1495-512. PubMed ID: 7635795
[TBL] [Abstract][Full Text] [Related]
16. Comparing Two Imaging Methods for Follow-Up of Lung Cancer Treatment: A Randomized Pilot Study.
Gambazzi F; Frey LD; Bruehlmeier M; Janthur WD; Graber SM; Heuberger J; Springer OS; Zweifel R; Boerner B; Tini GM; Irani S
Ann Thorac Surg; 2019 Feb; 107(2):430-435. PubMed ID: 30292847
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of recurrence and follow-up using FDG-PET/CT for postoperative non-small-cell lung cancer patients.
Toba H; Kawakita N; Takashima M; Matsumoto D; Takizawa H; Otsuka H; Tangoku A
Gen Thorac Cardiovasc Surg; 2021 Feb; 69(2):311-317. PubMed ID: 32909168
[TBL] [Abstract][Full Text] [Related]
18. Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis.
Pita-Fernández S; Alhayek-Aí M; González-Martín C; López-Calviño B; Seoane-Pillado T; Pértega-Díaz S
Ann Oncol; 2015 Apr; 26(4):644-656. PubMed ID: 25411419
[TBL] [Abstract][Full Text] [Related]
19. Postoperative Adverse Events are Associated with Oncologic Recurrence Following Curative-intent Resection for Lung Cancer.
Gowing S; Baker L; Tran A; Zhang Z; Ahn H; Ivanovic J; Anstee C; Grigor E; Gilbert S; Maziak DE; Shamji F; Sundaresan S; Villeneuve PJ; Seely AJE
Lung; 2020 Dec; 198(6):973-981. PubMed ID: 33034720
[TBL] [Abstract][Full Text] [Related]
20. Risk model-based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model.
Choi E; Luo SJ; Ding VY; Wu JT; Kumar AV; Wampfler J; Tammemägi MC; Wilkens LR; Aredo JV; Backhus LM; Neal JW; Leung AN; Freedman ND; Hung RJ; Amos CI; Le Marchand L; Cheng I; Wakelee HA; Yang P; Han SS
Cancer; 2024 Mar; 130(5):770-780. PubMed ID: 37877788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
